000			01530 a2200433 4500
005			20250513100015.0
264		0	_c19961204
008			199612s 0 0 eng d
022			_a0920-9964
024	7		_a10.1016/0920-9964(95)00096-8 _2doi
040			_aNLM _beng _cNLM
100	1		_avan Harten, P N
245	0	0	_aThe prevalence of tardive dystonia, tardive dyskinesia, parkinsonism and akathisia The Curaçao Extrapyramidal Syndromes Study: I. _h[electronic resource]
260			_bSchizophrenia research _cMay 1996
300			_a195-203 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAdult
650	0	4	_aAged
650	0	4	_aAkathisia, Drug-Induced _xepidemiology
650	0	4	_aAntipsychotic Agents _xadverse effects
650	0	4	_aCross-Sectional Studies
650	0	4	_aDyskinesia, Drug-Induced _xepidemiology
650	0	4	_aDystonia _xchemically induced
650	0	4	_aFemale
650	0	4	_aHumans
650	0	4	_aIncidence
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aNetherlands Antilles _xepidemiology
650	0	4	_aNeurologic Examination
650	0	4	_aParkinson Disease, Secondary _xchemically induced
650	0	4	_aRisk Factors
650	0	4	_aSchizophrenia _xdrug therapy
700	1		_aMatroos, G E
700	1		_aHoek, H W
700	1		_aKahn, R S
773	0		_tSchizophrenia research _gvol. 19 _gno. 2-3 _gp. 195-203
856	4	0	_uhttps://doi.org/10.1016/0920-9964(95)00096-8 _zAvailable from publisher's website
999			_c8786482 _d8786482